Company picked by Ottawa to produce made-in-Canada vaccines warns it may go out of business – CBC

Maryland-based Novavax says it has ‘substantial doubt’ about its ability to survive

Mar 01, 2023

The federal Liberal government’s COVID-19 vaccine manufacturing policy is facing yet another challenge after Maryland-based Novavax announced late Tuesday it may not have enough cash in a year’s time to stay in business.

That means three pillars of the government’s made-in-Canada COVID-19 vaccine procurement strategy have failed or could soon fail.

In addition to this new hiccup with cash-strapped Novavax, there was the doomed deal with China-based CanSino and a major investment in the now-defunct Medicago.

The government did, however, successfully procure tens of millions of COVID-19 doses from foreign companies like Pfizer and Moderna, firms that supplied highly effective shots that have saved an untold number of Canadians from severe outcomes and death.

Read more:

NationTalk Partners & Sponsors Learn More